EMEA-002600-PIP03-21-M01 - paediatric investigation plan

Pegcetacoplan
PIPHuman

Key facts

Invented name
Aspaveli
Active Substance
Pegcetacoplan
Therapeutic area
Renal and urinary disorders
Decision number
P/0030/2024
PIP number
EMEA-002600-PIP03-21-M01
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of glomerulonephritis and nephrotic syndrome
Route(s) of administration
Subcutaneous use
Contact for public enquiries

Apellis Ireland Limited 
Email: Regulatory-Info@apellis.com 
Tel.  +1 6179775700

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page